The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inflammatory Bowel Disease (IBD) Treatment Market Research Report 2024
Synopsis
Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.
The global Inflammatory Bowel Disease (IBD) Treatment market was valued at US$ 1614.5 million in 2023 and is anticipated to reach US$ 2749.1 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.
This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease (IBD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease (IBD) Treatment.
Report Scope
The Inflammatory Bowel Disease (IBD) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inflammatory Bowel Disease (IBD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease (IBD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Pfizer
Takeda
Janssen Biotech
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen
Segment by Type
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease (IBD) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.
The global Inflammatory Bowel Disease (IBD) Treatment market was valued at US$ 1614.5 million in 2023 and is anticipated to reach US$ 2749.1 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.
This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease (IBD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease (IBD) Treatment.
Report Scope
The Inflammatory Bowel Disease (IBD) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inflammatory Bowel Disease (IBD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory Bowel Disease (IBD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Pfizer
Takeda
Janssen Biotech
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen
Segment by Type
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease (IBD) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 TNF Inhibitors
1.2.3 Aminosalicyclates
1.2.4 Immunomodulators
1.2.5 Corticosteroids
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2019-2030)
2.2 Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Region
2.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Inflammatory Bowel Disease (IBD) Treatment Market Dynamics
2.3.1 Inflammatory Bowel Disease (IBD) Treatment Industry Trends
2.3.2 Inflammatory Bowel Disease (IBD) Treatment Market Drivers
2.3.3 Inflammatory Bowel Disease (IBD) Treatment Market Challenges
2.3.4 Inflammatory Bowel Disease (IBD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2019-2024)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
3.4 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2023
3.5 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2025-2030)
5 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2019-2030)
6.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2019-2024)
6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2019-2030)
7.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2019-2024)
7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size (2019-2030)
9.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2019-2024)
9.4 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction
11.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction
11.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction
11.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Detail
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Introduction
11.4.4 Janssen Biotech Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.4.5 Janssen Biotech Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction
11.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.5.5 Allergan Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Detail
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction
11.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.6.5 Bausch Health Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction
11.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Inflammatory Bowel Disease (IBD) Treatment Introduction
11.9.4 Biogen Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2019-2024)
11.9.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
